Why Diagnosing FHV Matters More Than You Think — Especially in Shelter and Multi-Cat Settings
Feline herpesvirus type 1 (FHV-1) is one of the most common viral pathogens in cats globally, responsible for a substantial proportion of upper respiratory tract disease (URTD) in kittens, shelter populations, and immunocompromised adults.[1] The clinical picture — sneezing, nasal discharge, conjunctivitis, and occasionally corneal lesions — overlaps significantly with feline calicivirus (FCV), Chlamydia felis, Bordetella bronchiseptica, and Mycoplasma spp. Without a confirmed diagnosis, you’re essentially treating empirically across a broad differential.
That empirical approach works much of the time in mild outpatient cases. But in shelter settings, multi-cat households, boarding facilities, or any context where infection control decisions carry real cost, knowing whether FHV is the actual driver changes things. It informs isolation protocols, vaccine program reviews, and whether famciclovir — which has a specific mechanism targeting FHV’s DNA polymerase — is truly warranted or whether resources are better spent elsewhere.
The problem historically has been access. PCR is the gold standard for FHV detection,[2] but it requires samples sent to a reference laboratory, turnaround times of one to several days, and cost that adds up quickly in volume settings. For a cat that’s already symptomatic and deteriorating, that delay is clinically meaningful. This is precisely the gap that point-of-care antigen detection addresses — not replacing PCR, but providing actionable information within minutes.
[IMAGE: fhv-conjunctival-swab-collection-veterinary-clinic.jpg | Alt: Veterinarian collecting conjunctival swab from a cat for feline herpesvirus antigen rapid test diagnosis]
The Sabervet Feline Herpesvirus Antigen Rapid Test, manufactured by ITGen, is designed to work at exactly this junction — ocular/nasal swab in, result in 10–15 minutes, no analyzer required. In busy shelter medicine or general practice, that kind of turnaround is the difference between a same-day treatment plan and a “let’s wait for the lab.” You can explore the full product details at the ITGen FHV antigen rapid test product page.
“A point-of-care test doesn’t replace clinical judgment — it informs it faster.”
It’s also worth noting the epidemiological significance: studies estimate that up to 97% of cats are exposed to FHV during their lifetime, and while most develop latent infection, stress-induced reactivation is common and clinically unpredictable.[3] In any cat presenting with recurrent ocular disease, rapid identification of the FHV component allows you to stratify between active viral replication (where antivirals are relevant) and immune-mediated sequelae (where the treatment logic is quite different).
Can a Rapid Antigen Test Actually Change Your Treatment Decision — Or Is It Just Confirmation Bias in a Strip?
This is a fair question, and it deserves a direct answer rather than marketing language.
In mild, self-limiting upper respiratory cases in otherwise healthy adult cats, a positive FHV antigen result probably doesn’t shift your initial management dramatically. You were likely going to provide supportive care — appetite stimulants (mirtazapine is the standard), mucolytics for thick secretions, and monitoring — regardless. In those cases, the test functions more as a record-keeping and client communication tool than a treatment pivot point.
But here are the scenarios where a confirmed feline herpesvirus test result does meaningfully change clinical decisions:
- Active corneal lesions: Dendritic or geographic ulcers are a hallmark of FHV ocular disease. A positive result in this context strongly supports initiating topical antiviral therapy — trifluridine (first choice per ABCD guidelines) or cidofovir 0.5% BID as a practical alternative — and avoiding topical corticosteroids, which can catastrophically worsen active epithelial disease.
- Recurrent cases: Cats presenting with the third or fourth episode of “conjunctivitis” benefit from confirmed FHV identification. It changes the conversation with the owner about lifelong management, stress reduction, vaccination strategy, and whether systemic famciclovir (90 mg/kg BID × 21 days) is justified.
- Shelter outbreak triage: When multiple cats are presenting simultaneously, knowing the pathogen drives isolation grouping and informs whether a cluster is FHV-dominant (vs. FCV, Chlamydia, or mixed). This has direct operational cost implications.
- Differentiating from Chlamydia/Mycoplasma: Both produce conjunctivitis with similar morphology, but the treatment hierarchy differs. FHV warrants topical antivirals; Chlamydia felis warrants doxycycline. A negative FHV rapid result nudges you toward bacterial etiology workup.
[IMAGE: sabervet-fhv-antigen-rapid-test-positive-result-strip.jpg | Alt: Sabervet FHV rapid antigen test kit showing a positive result on lateral flow strip for feline herpesvirus detection]
The Sabervet FHV test format — lateral flow, designed for conjunctival or nasal swab samples — aligns with the sample types that have the highest FHV-1 antigen yield during active acute infection. For a broader look at what rapid feline diagnostics are available in this format, the feline rapid test category gives a useful overview.
One honest caveat: antigen detection sensitivity is highest during the acute phase of active viral replication. In latently infected cats or in cases where viral shedding has subsided (but clinical signs persist due to immune-mediated mechanisms), antigen tests may return negative. This doesn’t mean the result is unhelpful — a negative still narrows your differential — but it means the test should be interpreted alongside clinical presentation, not as a binary verdict.
Which Drugs Actually Work for FHV — and Which Ones Are You Still Prescribing Out of Habit?
Let’s be direct: some FHV treatment habits in veterinary practice don’t hold up well under current evidence. Here’s a structured look at the drug landscape, organized the way clinicians actually think — by situation, not by alphabetical ingredient list.
| Clinical Scenario | Recommended Approach | Key Drugs | What to Avoid |
|---|---|---|---|
| Mild URTD, no corneal lesions | Supportive care first | Mirtazapine (1.88–2 mg/cat SID), bromhexine for thick secretions, hydration | Reflexive antivirals unless risk factors present |
| Suspected secondary bacterial infection, purulent discharge | Antibiotics with respiratory penetration | Doxycycline 5–10 mg/kg q12–24h (first line); amoxicillin 20 mg/kg q8h (alternative) | Broad-spectrum without indication |
| Acute conjunctivitis + corneal epithelial lesions | Topical antiviral, avoid steroids | Trifluridine (q1h Day 1, then q4h); cidofovir 0.5% BID; ganciclovir 0.15% gel q8h (most accessible) | Topical or systemic corticosteroids |
| Severe/recurrent ocular disease, systemic illness, topical application difficult | Systemic antiviral | Famciclovir 90 mg/kg PO BID × 21 days (ABCD-endorsed first-line systemic) | Systemic acyclovir (weak FHV activity, toxicity risk); L-lysine (no reliable evidence) |
| Anorexia >3 days, marked lethargy | Nutritional support prioritized | Feeding tube if needed; appetite stimulant (mirtazapine); IV/SC fluids | Adding more antivirals before stabilizing nutritional status |
| Chronic stromal keratitis / sequestrum | Re-classify before treating | May require immune modulation — different logic than acute epithelial disease | Continuing antivirals mechanically without re-staging the disease |
A few things worth highlighting from this table:
L-lysine is no longer recommended. The ABCD feline respiratory guidelines are unambiguous on this: there is insufficient reliable evidence to support L-lysine as either a prophylactic or therapeutic agent for FHV. If it’s still in your protocol, it’s time to remove it.[4]
Famciclovir is the only orally bioavailable antiviral with meaningful evidence in cats. Unlike acyclovir — which cats metabolize poorly and which carries systemic toxicity risk — famciclovir is converted in feline tissue to penciclovir, an active FHV-1 inhibitor. The 90 mg/kg BID × 21-day regimen is now considered standard for moderate-to-severe or recurrent cases.[5]
Corticosteroid timing matters enormously. They are contraindicated during acute epithelial FHV disease (dendritic/geographic ulcers). In chronic stromal disease — where immune-mediated pathology is driving progression rather than active viral replication — they may be cautiously considered. Conflating these two phases leads to poor outcomes.
[IMAGE: fhv-treatment-medications-famciclovir-trifluridine-doxycycline-vet.jpg | Alt: Veterinary clinician reviewing feline herpesvirus treatment protocol with drug comparison chart for FHV-1 management]
For clinics looking to standardize their feline respiratory diagnostic toolkit alongside treatment protocols, a visit to the full diagnostics product range is worth your time — particularly if you’re managing multi-cat facilities or building out a point-of-care panel.
Frequently Asked Questions About FHV Diagnosis and the Sabervet Rapid Test
How accurate is a feline herpesvirus antigen rapid test compared to PCR?
Antigen rapid tests detect FHV-1 viral proteins directly from swab samples during active infection. PCR detects viral DNA and is generally more sensitive, particularly in subclinical or post-acute cases. Antigen tests trade some sensitivity for speed and accessibility — they perform best when used during the acute symptomatic phase when viral load and shedding are highest. For definitive diagnosis in ambiguous or post-acute cases, PCR remains the reference standard. In acute clinical settings, the feline herpesvirus test kit format is a practical first-line tool.
What sample type should I use for the Sabervet FHV test?
Conjunctival swabs and nasal swabs are the primary sample types. Conjunctival swabs tend to yield higher antigen concentrations in cats with active ocular disease. For cats with predominantly respiratory signs, a combined nasal/pharyngeal swab is appropriate. Sample collection technique matters — ensure you’re making firm contact with the mucosal surface rather than just swabbing surface discharge.
Can I use this test in kittens?
Yes — in fact, kittens are among the highest-priority use cases. FHV-1 is particularly severe in neonates and young kittens, where rapid diagnosis can accelerate the decision to start famciclovir or intensify supportive care. Maternally derived antibodies may affect some serology-based tests, but antigen detection is not affected by antibody status, making it reliable across age groups.
Does a positive FHV test mean I should automatically start famciclovir?
Not automatically. A positive result confirms active FHV-1 antigen presence, but treatment intensity should still be matched to clinical severity. Mild cases in healthy adults may still be managed supportively; famciclovir is indicated when ocular disease is significant (corneal ulceration, chronic or recurrent disease), when the cat is systemically unwell, or when topical antiviral application isn’t feasible. The test informs the decision — it doesn’t replace clinical staging.
Where is the Sabervet FHV test manufactured, and is it available for bulk purchase?
The test is developed and manufactured by ITGen (Hangzhou ITGen Technology Co., Ltd.), a veterinary diagnostics company with production facilities in China. The FHV test factory-direct supply model means competitive pricing for clinic groups, shelters, and distributors. Bulk and wholesale supply options are available through ITGen’s dedicated channels (see the CTA section below).
Is the Sabervet FHV test validated for use with ocular discharge specifically?
The test is designed for use with swabs from active lesion sites — conjunctival/ocular and nasal mucosa. Direct ocular discharge samples are not the recommended format; a swab from the conjunctival fornix provides more consistent sample standardization and avoids the dilution effect that can occur with watery discharge. Follow the product IFU for precise collection instructions.
Conclusion
FHV-1 is not a diagnosis to reach for by default every time a cat sneezes — but it’s also not one to dismiss when the clinical picture fits. The practical reality of feline herpesvirus management is that good outcomes depend less on exotic pharmaceuticals and more on the right diagnosis at the right time, followed by matched treatment intensity.
Point-of-care antigen testing like the Sabervet feline herpesvirus test sits in a genuinely useful position in that workflow: it’s fast enough to inform same-visit decisions, accessible enough to use in general practice and shelter settings, and specific enough to distinguish FHV from the significant differential list that mimics it.
The drug landscape is clearer than many practitioners realize: famciclovir for systemic cases, trifluridine or cidofovir topically for corneal disease, doxycycline when secondary bacterial infection is likely, and supportive care — fluids, appetite stimulation, nutrition — as the foundation everything else is built on. L-lysine is out. Corticosteroids in active epithelial disease are out. Getting the diagnosis right, early, makes every subsequent decision better.
Find the Sabervet FHV Test and Related Diagnostics
Whether you’re stocking a single clinic or sourcing at scale for a shelter network or distributor, here’s where to go:
For individual clinic orders and the full feline test range, visit our veterinary diagnostics online store — direct shipping, wide product selection.
For volume purchasing, wholesale pricing, and multi-species panels, explore pet healthy supplies bulk sale through ITGen’s main procurement portal.
For OEM, private-label, or distributor-level supply, Sabervet livestock diagnostics and pet diagnostics bulk sale is the right channel — factory-direct pricing with regulatory documentation support.
References
- Thiry E, et al. “Feline herpesvirus infection: ABCD guidelines on prevention and management.” Journal of Feline Medicine and Surgery. 2009;11(7):547–555. https://doi.org/10.1016/j.jfms.2009.05.006
- Sykes JE. “Feline upper respiratory tract pathogens in the United Kingdom: a case-controlled study of the association of Chlamydophila felis, feline calicivirus and feline herpesvirus with clinical signs of disease.” Veterinary Record. 2001;148(13):387–392. https://doi.org/10.1136/vr.148.13.387
- Gould D. “Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options.” Journal of Feline Medicine and Surgery. 2011;13(5):333–346. https://doi.org/10.1016/j.jfms.2011.03.010
- Drazenovich TL, Fascetti AJ, Westermeyer HD, et al. “Effects of dietary lysine supplementation on upper respiratory and ocular disease and detection of infectious organisms in cats within an animal shelter.” American Journal of Veterinary Research. 2009;70(11):1391–1400. https://doi.org/10.2460/ajvr.70.11.1391
- Thomasy SM, Maggs DJ. “A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1.” Veterinary Ophthalmology. 2016;19 Suppl 1:119–130. https://doi.org/10.1111/vop.12375
